North America Antimicrobial Susceptibility Testing Market: by Type (Disk Diffusion, Rapid Automated, E-test, Broth Dilution, Agar Dilution, Genotypic Methods), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology, Veterinary Applications, Environmental Monitoring, Others), Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors/Wholesalers, Group Purchasing Organizations, Others), Technology (Molecular Testing, Automated AST, Manual Testing, Spectroscopy-based, Microarrays, Others), Organization Size (Small, Medium, Large) and By North America – Historical & Forecast Period (2020-2035) Comprehensive Study 2025

1. North America Antimicrobial Susceptibility Testing Market Outlook

2. North America Antimicrobial Susceptibility Testing Market Executive Summary

2.1. North America Market Revenue Size (USD Million) (2020-2035)

2.2. Key Trends By Segments (2020-2035)

2.3. Key Trends By North America (2020-2035)

3. North America Antimicrobial Susceptibility Testing Market Key Vendors Analysis

3.1. Antimicrobial Susceptibility Testing Market Regulatory Framework

3.2. Antimicrobial Susceptibility Testing Market New Business and Ease of Doing Business Index

3.3. Antimicrobial Susceptibility Testing Market Recent Developments

3.4. Top Antimicrobial Susceptibility Testing Market Buyers Details By North America

3.5. Top Antimicrobial Susceptibility Testing Market Suppliers Details By North America

3.6. Case Studies of Successful Key Ventures

3.7. Top Players Comparative Analysis

3.7.1. Country/Regions

3.8. Key Vendors

3.8.1. Top 5 Antimicrobial Susceptibility Testing Market Vendors Pricing Analysis

3.8.2. Antimicrobial Susceptibility Testing Market Product Benchmarking

3.8.3. Antimicrobial Susceptibility Testing Market Future Investment Plans

3.9. Antimicrobial Susceptibility Testing Market – Forces

3.9.1. Antimicrobial Susceptibility Testing Market Drivers

3.9.2. Antimicrobial Susceptibility Testing Market Restraints

3.9.3. Antimicrobial Susceptibility Testing Market Challenges

3.9.3.1. Porter's Five Forces Analysis

3.9.3.1.1. Antimicrobial Susceptibility Testing Market Bargaining Power of Suppliers

3.9.3.1.2. Antimicrobial Susceptibility Testing Market Bargaining Power of Buyers

3.9.3.1.3. Antimicrobial Susceptibility Testing Market Threat of New Entrants

3.9.3.1.4. Antimicrobial Susceptibility Testing Market Threat of Substitutes

3.9.3.1.5. Antimicrobial Susceptibility Testing Market Degree of Competition

4. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) Size (2020-2035)- By Country Analysis

4.1. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) By Country (2020-2035)

4.1.1. US

4.1.2. Canada

4.1.3. Mexico

5. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) Size (2020-2035)- By Type

5.1. Disk Diffusion

5.2. Rapid Automated AST

5.3. E-test

5.4. Broth Dilution

5.5. Agar Dilution

5.6. Genotypic Methods

6. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) Size (2020-2035)- By Application

6.1. Clinical Diagnostics

6.2. Drug Discovery and Development

6.3. Epidemiology

6.4. Veterinary Applications

6.5. Environmental Monitoring

6.6. Others

7. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) Size (2020-2035)- By Technology

7.1. Molecular Testing

7.2. Automated AST

7.3. Manual Testing

7.4. Spectroscopy-based

7.5. Microarrays

7.6. Others

8. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) Size (2020-2035)- By Distribution Channels

8.1. Direct Tender

8.2. Retail Sales

8.3. Online Sales

8.4. Distributors/Wholesalers

8.5. Group Purchasing Organizations

8.6. Others

9. North America Antimicrobial Susceptibility Testing Market Revenue (USD Million) Size (2020-2035)- By Organization Size

9.1. Small

9.2. Medium

9.3. Large

10. Company Profile Analysis

10.1. bioMérieux SA

10.1.1. Vendors Overview

10.1.2. Business Portfolio

10.1.3. Geographical Portfolio

10.1.4. Customers

10.1.5. Financial Analysis

10.2. Becton, Dickinson and Company (BD)

10.3. Thermo Fisher Scientific Inc.

10.4. Danaher Corporation

10.5. Bruker Corporation

10.6. Creative Diagnostics

10.7. Bio-Rad Laboratories, Inc.

10.8. Accelerate Diagnostics, Inc.

10.9. Hardy Diagnostics

10.10. Sekisui Diagnostics

10.11. Liofilchem Srl

10.12. Merck KGaA

10.13. ELITechGroup

10.14. HiMedia Laboratories Pvt. Ltd.

10.15. Vela Diagnostics

11. Sources Covered

11.1. Primary Sources

11.2. Secondary Sources